furazolidone has been researched along with Leishmaniasis, Cutaneous in 2 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment used furazolidone + β-cyclodextrin complex (1: 2) at a concentration of 60 mg/mL given orally at a dose of 15 mg/kg every 12 hours." | 1.72 | Treatment of canine cutaneous leishmaniasis by Leishmania (Viannia) braziliensis in dogs with furazolidone and β-cyclodextrin: case report. ( Ataíde Siqueira, L; Gnecco Zanini, D; Madureira, AP; Ramos Sobreira, R; Santos Zanini, M; Savergnini Poleze, L; Vieira Almeida, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santos Zanini, M | 1 |
| Ataíde Siqueira, L | 1 |
| Vieira Almeida, Y | 1 |
| Savergnini Poleze, L | 1 |
| Gnecco Zanini, D | 1 |
| Ramos Sobreira, R | 1 |
| Madureira, AP | 2 |
| Passos, SR | 1 |
| Rodrigues, Tde A | 1 |
| Giunchetti, RC | 1 |
| Zanini, MS | 1 |
2 other studies available for furazolidone and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Treatment of canine cutaneous leishmaniasis by Leishmania (Viannia) braziliensis in dogs with furazolidone and β-cyclodextrin: case report.
Topics: Animals; Anti-Infective Agents, Local; beta-Cyclodextrins; Brazil; Dog Diseases; Dogs; Furazolidone; | 2022 |
Clinical treatment of cutaneous leishmaniasis in dogs with furazolidone and domperidone.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Domperidone; Female; Furazolidone; Leishmania bra | 2014 |